Published in
JMIR Publications, JMIR Research Protocols, 2(4), p. e79, 2015
DOI: 10.2196/resprot.4320
Links
- JMIR Publications
- ORCID
- ORCID
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [repository.ubn.ru.nl] | PDF
- [dspace.library.uu.nl] | PDF
Tools
Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol
Journal article published in 2015 by
Bo Jan Noordman 
,
Joel Shapiro ,
Manon Cw Spaander ,
Kausilia K. Krishnadath ,
Hanneke Wm van Laarhoven ,
Mark I. van Berge Henegouwen ,
Grard Ap Nieuwenhuijzen ,
Richard van Hillegersberg ,
Meindert N. Sosef ,
Ewout W. Steyerberg ,
Bas Pl Wijnhoven ,
J. Jan B. van Lanschot
,
Joel Shapiro ,
Manon Cw Spaander ,
Kausilia K. Krishnadath ,
Hanneke Wm van Laarhoven ,
Mark I. van Berge Henegouwen ,
Grard Ap Nieuwenhuijzen ,
Richard van Hillegersberg ,
Meindert N. Sosef ,
Ewout W. Steyerberg ,
Bas Pl Wijnhoven ,
J. Jan B. van Lanschot
This paper is made freely available by the publisher.
Full text: Download
Data provided by 